Log in to save to my catalogue

Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children recei...

Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children recei...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_915632332

Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia

About this item

Full title

Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia

Publisher

London: Nature Publishing Group UK

Journal title

Bone marrow transplantation (Basingstoke), 2012-01, Vol.47 (1), p.107-114

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

We evaluated the incidence of GVHD, risk factors and the impact of graft composition on acute GVHD (aGVHD) in 92 children who underwent BMT for thalassemia following busulfan/cyclophosphamide (BUCY)-based conditioning regimens and GVHD prophylaxis with CSA/short-MTX and methylprednisolone. The incidence of grade 2–4 and 3–4 aGVHD was 35% (95% confi...

Alternative Titles

Full title

Higher CD3+ and CD34+ cell doses in the graft increase the incidence of acute GVHD in children receiving BMT for thalassemia

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_915632332

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_915632332

Other Identifiers

ISSN

0268-3369

E-ISSN

1476-5365

DOI

10.1038/bmt.2011.3

How to access this item